Document is current

Any future updates will be listed below

Activity of selpercatinib confirmed in phase III trials

Crossref DOI link: https://doi.org/10.1038/s41571-023-00837-z

Published Online: 2023-11-02

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark